Search

Your search keyword '"Lawrence L. Horstman"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Lawrence L. Horstman" Remove constraint Author: "Lawrence L. Horstman" Journal blood Remove constraint Journal: blood
58 results on '"Lawrence L. Horstman"'

Search Results

1. In Contrast to Platelet Microparticles, Red Cell Microparticles Are Anti-Inflammatory, Judging By Effect on CD11b Expression on Neutrophils

2. Microparticle Profiles in Patients with TTP Vs. ITP

3. Cell Derived Microparticles (MP) in Different Phases of Thrombotic Thrombocytopenic Purpura (TTP) and Effect of Exchange Plasmapheresis (EPP) on Their Profiles

4. Functional Heterogeneity of Red Cell-Derived Microparticles from Different Sources: Calcium Ionophore Vs. Storage Vs. Extrusion

5. Evidence for Anti-Fibrinolytic Activity of Red Cell-Derived Microparticles (RMP): A Novel Hemostatic Action of RMP

6. Pharmacokinetics of Red Cell-Derived Microparticles (RMP) in Rabbits and Rats: Effects of Administration Regimen and Labels for Assay

7. Elevated Red Cell Microparticles (RMP) in Hematologic and Thrombotic Disorders

8. Correlations of Red Cell-Derived Micropareticles (RMP) with Other MP Species in Hematological and Thrombotic Disorders

9. Second Generation Direct-Acting Antiviral Agents Eradicate Hepatitis C Virus (HCV) but Exacerbate Thrombocytopenia in a Patient with HCV-Associated Immune Thrombocytopenic Purpura (ITP): Case Report

10. Comparison of Pharmacokinetics and Hemostatic Efficacy of Red Cell Microparticles (RMP) in Rabbits Using Different Infusion Regimens

11. Transfusion with Washed vs. Unwashed Packed Red Cells in Coronary Artery Bypass Graft (CABG) Surgery: Major Outcome Differences

12. Preferential Stimulation of Contact Pathway Factors By Red Cell-Derived Microparticles: New Perspective on Hemostasis

13. Efficacy Trial In An Acute Liver Trauma Animal Model Of Novel Infusible Hemostatic Product: Red Blood Cell-Derived Microparticles (RMP)

14. Release of Microparticles During Blood Storage Is Influenced by Residual Platelets, Leukocytes and Oxygen Levels

15. Red Cell-Derived Microparticles (RMP) As Hemostatic Agent: Evaluation in a Rabbit Ear Bleeding Model

16. Interaction of Red Cell Microparticles (RMP) with Platelets: Potential Role of RMP in Hemostasis and Thrombosis

17. Red Cell Microparticles (RMP) Correct Factor Deficiencies and Hemodilution: Evaluation by Thromboelastography (TEG)

18. Red Cell Microparticles (RMP) As Hemostatic Agent: Summary of Recent Advances

19. Release of Procoagulant and Proinflammatory Cell-Derived Microparticles (MP) During Blood Storage: Effects of Storage Time, Leukoreduction, and Residual Platelets

20. Red Cell-Derived Microparticles (RMP) Correct or Improve Abnormal Coagulation Profiles in TEG in a Variety of Disorders of Different Pathology

21. Influence of Cell-Derived Microparticles on Thromboelastography

22. Elevated Complement (C) and IgG Bound Microparticles (MP) in Immune Thrombocytopenic Purpura (ITP) and Hemolytic Anemia (HA)

23. Increased Acetylcholinesterase Activity of Microparticles Derived from Red Cells (RMP) Compared to Platelets (PMP)

24. Surface Adhesion and Growth of Microaggregates under Flow Condition (II): Clinical Findings in Patients with Thrombosis and Thrombocytopenia

25. Effects of Intravenous Immunoglobulins (IVIG) on Cell-Derived Microparticles in Patients with ITP

26. Increased Endothelial Colony-Forming Cells (ECFC) and Endothelial Microparticles (EMP) and Their Interaction in Thrombotic Thrombocytopenic Purpura (TTP)

27. Cell-Derived Microparticles in ITP Patients with vs. without Bleeding Tendency

28. Cell-Derived Microparticle (C-MP) Profiles in Lymphoproliferative Disorders: Association of Elevated Red Cell Microparticles (RMP) with Thrombosis

29. Surface Adhesion and Growth of Microaggregates under Flow Conditions (I): Role of Cell-Derived Microparticles and Leukocytes

30. Elevated Red Cell Microparticles (RMP) as Risk Factor for Thrombosis in Patients with Renal Failure

31. Danazol with Intermittent Chemotherapy Induces Lasting Remissions in Advanced and Refractory MPD in Elderly Patients

32. A Significant Fraction of ADAMTS13 Activity Is Associated with Activated Platelets and Their Microparticles (PMP): Implication for Regulating ADAMTS13 Activity

33. Association of Endothelial Microparticles (EMP) and Endothelial Progenitors with Serum Cholesterol Levels

34. Endothelial Microparticles (EMP) and Their Interactions with Leukocytes in HIV Infected Patients with Optimal Response to Highly Active Antiretroviral Therapy (HAART)

35. Antibodies Against Platelet Glycoprotein Target Antigens in Antiphospholipid Syndrome (APS)

36. Recurrent Thrombosis Is Frequently Associated with Increased Microparticle-Mediated Thrombin Generation

37. Multiple Species of Endothelial Microparticles (EMP) Released from Different Membrane Protein Clustering Domains Exhibit Distinctive Phenotypes and Activities

38. Microparticles Are Active Components of Therapeutic Plasma Exchange: Correlation with ADAMTS13 Activity in Patients with Thrombotic Thrombocytopenic Purpura

39. Anti-Platelet Glycoprotein Antibodies in Thrombocytosis Are Frequently Detected and Are Associated with Platelet Activation and Thrombosis

40. Thrombin Generation Profiles Are Qualitatively and Quantitatively Distinct in Microparticles Derived from Red Cells (RMP), Platelets (PMP), and Endothelia (EMP)

41. Profile of Cell-Derived Microparticles (C-MP) in ITP: Red Cell Microparticles (RMP) Correlate with Severity of ITP

42. Platelet Microparticles, Platelet Activation and Platelet-Leukocyte Conjugates in HIV Infected Patients with Optimal Response to Highly Active Antiretroviral Therapy (HAART)

43. Activation of Clotting Factors in Thrombocytopenia Due to Platelets Destruction: A Possible Compensated Mechanism for Hemostasis

44. Soluble CD30 (sCD30), a Marker of Th2 Polarization, Is Elevated in Patients with Autoimmune Hemolytic Anemia (AIHA) but Not with Idiopathic Thrombocytopenia (ITP)

45. Microparticles Derived from Platelets (PMP), Endothelia (EMP), and Leukocytes (LMP) Exhibit Distinctive Hemostatic and Inflammatory Activities

46. Profiles of Antibodies Specific to Platelet Glycoproteins in ITP Differ in Remission, Relapse and Stable Phases; and Anti-GpIIb/IIIa, -GpIb/IX Were Associated with Bleeding Manifestations

47. Rituximab Therapy Induces Long Lasting Clinical Remissions and Reduction of Anti-Platelet Glycoprotein Autoantibodies in Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

48. Hepatitis C Associated ITP: High Incidence of Autoantibodies Specific to Platelet Glycoproteins and Favorable Response to IL-11

49. Platelet Binding to Leukocytes as a Determinant of Leukocyte Activation In Vivo

50. Correlation between Entothelial Microparticle Binding to Monocytes and Monocyte Nitric Oxide Production in Prothrombotic and Inflammatory Disorders

Catalog

Books, media, physical & digital resources